Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Systemic therapy may reduce male infertility in psoriasis patients.

Nocturia cases increased, but medication use declined, suggesting under-treatment.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

Drug repurposing can create safer, cheaper treatments by finding new uses for existing drugs.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

People with hidradenitis suppurativa have a higher risk of kidney stones.

GLP-1RA therapy may increase the risk of hair loss.

Long-COVID causes more health issues after COVID-19, varying by age, sex, and infection wave.

Alopecia areata patients often face mental health issues like anxiety and depression.

Dupilumab users have a higher risk of developing alopecia areata.

IBS is linked to certain skin conditions like psoriasis and rosacea, and vice versa.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

GLP-1 receptor agonists may help or harm hair health, needing more research.

Oral 5-alpha-reductase inhibitors for hair loss don't increase heart risk.

Taking medication for hair loss might cause sexual problems.

GLP-1 agonists may help treat certain skin conditions.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Low-dose oral minoxidil doesn't affect blood pressure in patients taking blood pressure meds.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.